Tocilizumorelikeit? The latest data on Tocilizumab. St Emlyn’s
A January 2021 appraisal of REMAP-CAP’s early tocilizumab and sarilumab findings in critically ill patients with COVID-19. Dan Horner examines organ support and survival outcomes, strict eligibility criteria and the uncertainties that remained as the results moved rapidly into policy and public discussion.
Tocilizumorelikeit? The latest data on Tocilizumab. St Emlyn’s Read More








